Behnaz Heydarchi
Dr. Behnaz Heydarchi is an immunologist with a strong expertise in developing novel therapeutic and prophylactic antibodies. She earned her PhD from the University of Melbourne in 2016. During her subsequent 4-year postdoctoral tenure at the Peter Doherty Institute, she made remarkable advancements in generating highly potent therapeutics and prophylactics targeting infectious diseases. In 2020, she joined the Walter and Eliza Hall Institute, where she and her team are focused to understand the mechanism of Haemolytic Disease (HDN) of the Newborn. The goal is to enhance maternal-fetal health outcomes by developing novel antibodies for prevention of HDN.
Abstracts this author is presenting:
